Literature DB >> 15916617

Mechanisms in IBS: something old, something new, something borrowed...

M Camilleri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15916617     DOI： 10.1111/j.1365-2982.2004.00632.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN： 1350-1925            Impact factor:   3.598


× No keyword cloud information.
  23 in total

1.  Association of TNFSF15 polymorphism with irritable bowel syndrome.

Authors:  Marco Zucchelli; Michael Camilleri; Anna Nixon Andreasson; Francesca Bresso; Aldona Dlugosz; Jonas Halfvarson; Leif Törkvist; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Richard H Duerr; Magnus Simren; Greger Lindberg; Lars Agreus; Paula Carlson; Alan R Zinsmeister; Mauro D'Amato
Journal:  Gut       Date:  2011-06-02       Impact factor: 23.059

2.  Altered purinergic signaling in colorectal dorsal root ganglion neurons contributes to colorectal hypersensitivity.

Authors:  Masamichi Shinoda; Jun-Ho La; Klaus Bielefeldt; G F Gebhart
Journal:  J Neurophysiol       Date:  2010-09-22       Impact factor: 2.714

3.  Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.

Authors:  M Camilleri; P Carlson; S McKinzie; M Zucchelli; M D'Amato; I Busciglio; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 3.598

4.  Deployment-associated functional gastrointestinal disorders: do we know the etiology?

Authors:  Ashok K Tuteja
Journal:  Dig Dis Sci       Date:  2011-11       Impact factor: 3.199

5.  Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.

Authors:  Chloé Melchior; Moutaz Aziz; Typhaine Aubry; Guillaume Gourcerol; Muriel Quillard; Alberto Zalar; Moïse Coëffier; Pierre Dechelotte; Anne-Marie Leroi; Philippe Ducrotté
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

Review 6.  Irritable bowel syndrome: recent and novel therapeutic approaches.

Authors:  Viola Andresen; Michael Camilleri
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D).

Authors:  Yang Won Min; Poong-Lyul Rhee
Journal:  Therap Adv Gastroenterol       Date:  2015-05       Impact factor: 4.409

Review 8.  Current and novel therapeutic options for irritable bowel syndrome management.

Authors:  M Camilleri; V Andresen
Journal:  Dig Liver Dis       Date:  2009-08-08       Impact factor: 4.088

9.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

10.  Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.

Authors:  Jeroen Aerssens; Michael Camilleri; Willem Talloen; Leen Thielemans; Hinrich W H Göhlmann; Ilse Van Den Wyngaert; Theo Thielemans; Ronald De Hoogt; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Busciglio; Duane D Burton; Thomas Smyrk; Raul Urrutia; Bernard Coulie
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.